Biosynex (ALBIO) — Free Cash Flow Generation Index
Latest as of December 2024:
-1.19x
Biosynex (ALBIO) has a Free Cash Flow Generation Index of -1.19x as of December 2024. Free cash flow of €-1.51 Million represents -1% of operating cash flow (€1.26 Million). See working capital to net assets of Biosynex to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
-1.19x
Free Cash Flow / Operating CF
Free Cash Flow
€-1.51 Million
EUR
Operating Cash Flow
€1.26 Million
EUR
Capital Expenditures
€2.77 Million
EUR
Biosynex Free Cash Flow Generation Index (2009–2022)
Historical FCF Generation Index trend for Biosynex across 9 annual periods. Explore Biosynex debt service capacity to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Biosynex (2009–2022)
Year-by-year Free Cash Flow Generation Index for Biosynex. For the full company profile including market capitalisation, see Biosynex stock valuation.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2022 | -5.08x | €-25.13 Million | €4.95 Million | €30.08 Million | ▼ -714.6% |
| 2021 | 0.83x | €90.82 Million | €109.83 Million | €19.02 Million | ▲ +16.2% |
| 2020 | 0.71x | €22.52 Million | €31.64 Million | €9.12 Million | ▼ -28.8% |
| 2019 | 1.00x | €1.10 Million | €1.10 Million | €9.12 Million | ▲ +0.0% |
| 2018 | 1.00x | €467.12K | €467.12K | €9.12 Million | ▲ +0.0% |
| 2017 | 1.00x | €484.82K | €484.82K | €9.12 Million | ▲ +0.0% |
| 2016 | 1.00x | €489.91K | €489.91K | €0.00 | ▲ +0.0% |
| 2015 | 1.00x | €461.66K | €461.66K | €0.00 | ▲ +184.2% |
| 2009 | 0.35x | €25.48K | €72.40K | €46.92K | — |
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).